Patient-specific pluripotent stem cells become even more accessible.
about
Generation of induced pluripotent stem cells from human renal proximal tubular cells with only two transcription factors, OCT4 and SOX2Induced Pluripotent Stem Cell Therapies for Cervical Spinal Cord InjuryInduced pluripotent stem cells as a disease modeling and drug screening platformGeneration and characterization of functional cardiomyocytes derived from human T cell-derived induced pluripotent stem cellsPresent and future challenges of induced pluripotent stem cellsLIF-dependent signaling: new pieces in the LegoGeneration of induced pluripotent stem cells from CD34+ cells across blood drawn from multiple donors with non-integrating episomal vectorsSignaling adaptor protein SH2B1 enhances neurite outgrowth and accelerates the maturation of human induced neuronsNovel Markov model of induced pluripotency predicts gene expression changes in reprogrammingImmunological barriers to stem-cell based cardiac repairInduced pluripotent stem cells: opportunities and challenges.Generation of melanocytes from induced pluripotent stem cellsProgress in cell grafting therapy for temporal lobe epilepsy.The current status of iPS cells in cardiac research and their potential for tissue engineering and regenerative medicine.Evolution of energy metabolism, stem cells and cancer stem cells: how the Warburg and Barker hypothesis might be linked.The Generation of Human Induced Pluripotent Stem Cells from Blood Cells: An Efficient Protocol Using Serial Plating of Reprogrammed Cells by Centrifugation.Blood Derived Induced Pluripotent Stem Cells (iPSCs): Benefits, Challenges and the Road Ahead.Current advances in cell therapy strategies for muscular dystrophies.The use of induced pluripotent stem cells in drug development.Prospects for pluripotent stem cell therapies: into the clinic and back to the bench.Induced pluripotent stem cells and severe combined immunodeficiency: merely disease modeling or potentially a novel cure?Invited review: Stem cells and muscle diseases: advances in cell therapy strategies.Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures.New Directions in Gaucher Disease.Cultivate Primary Nasal Epithelial Cells from Children and Reprogram into Induced Pluripotent Stem Cells.Cell transplantation and gene therapy in Parkinson's disease.Stem cells. Epigenome disruptors.Maintenance of feeder free anchorage independent cultures of ES and iPS cells by retinol/vitamin A.Myocardial Reprogramming Medicine: The Development, Application, and Challenge of Induced Pluripotent Stem Cells
P2860
Q24631565-BFABAF7B-E7C7-47C3-B68E-E3A838DEC9C9Q26748907-ACDC8805-12CC-4E27-BCDA-0AC2F1554B6EQ26865689-AB95F5C1-0872-4EE0-ABF8-66B79CE45A99Q27333621-EFFF320A-15F0-4FB6-9178-73FC5745113AQ28082747-55010117-CD07-4772-9E82-50FBD1C4D418Q28731796-800A3520-82D9-47B4-AA4D-F3CE4370BF3BQ28742368-2CA1CA82-915A-4E94-A201-36E4B800B286Q30579310-09155A04-C956-4620-8946-AC17F2F8F34DQ34333474-EB4419CE-7074-4715-BE6F-83066CC877CDQ34774684-57137C1A-E843-40A2-AE0D-D1C401501572Q35088515-02C9C71F-A6E0-4CB9-9A19-2C039C7A99C3Q35541870-EC321663-A7B0-4141-9EE4-4936271614BFQ35648123-66656CB7-6756-46CD-93F4-95FEDC50D60FQ35765543-C1FF649B-0F91-4A1B-ABCB-B2B8851AB9A0Q36760853-3B4CCBB8-B0CB-49E9-8A97-19CF781556B7Q37184632-CD27D75C-FB85-4C15-AD0E-310237693004Q37427137-3E531754-BD53-41D4-BA20-51854A20A1A5Q37827157-F2F586F1-A9D1-4E53-BEBE-7D3B3A129E36Q37856714-7FEE35EE-D75D-4AAA-8B49-CF39D4ABA369Q37934739-2ED52728-A53F-4EE1-A6A5-DF88927A8C49Q37995010-13D92256-68DC-48A6-A854-9A663C656CACQ38269131-FC418FC4-A99C-4F3C-8A48-16E6C3FFDC93Q38706487-13F2883D-A555-4D37-9AF0-227D8DF29592Q38905996-30E2F6F4-F341-4039-BDED-2BEFC41B29B7Q39009739-BEC9EDDB-AD47-457A-9C77-2584BE92D912Q44297524-2AC4ED43-D8A6-4153-AE3C-CD7927B9A228Q51896950-1865ED9B-FD3A-4C43-B3F3-11413F3BBA51Q54311182-08B3C763-ED06-490E-8229-A4CA45C31E8DQ59072379-636CD4A5-455A-4625-8EDB-505EE353FD7C
P2860
Patient-specific pluripotent stem cells become even more accessible.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Patient-specific pluripotent stem cells become even more accessible.
@ast
Patient-specific pluripotent stem cells become even more accessible.
@en
Patient-specific pluripotent stem cells become even more accessible.
@nl
type
label
Patient-specific pluripotent stem cells become even more accessible.
@ast
Patient-specific pluripotent stem cells become even more accessible.
@en
Patient-specific pluripotent stem cells become even more accessible.
@nl
prefLabel
Patient-specific pluripotent stem cells become even more accessible.
@ast
Patient-specific pluripotent stem cells become even more accessible.
@en
Patient-specific pluripotent stem cells become even more accessible.
@nl
P1433
P1476
Patient-specific pluripotent stem cells become even more accessible.
@en
P356
10.1016/J.STEM.2010.06.009
P407
P577
2010-07-01T00:00:00Z